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Patient satisfaction, including the degree of pain experienced, is specifically an important part 
of quality assurance (QA) for endoscopic retrograde cholangiopancreatography (ERCP).1-4 
However, variations in the definitions and variables applied have made comparisons among 
studies difficult,1,5,6 and well-designed, validated instruments for proper evaluation are 
lacking. 
Endoscopists generally agree that the ERCP procedure is associated with significant 
discomfort and pain for most patients, and appropriate sedation is typically justified. 
Nevertheless, even though the ERCP procedure has been performed for four decades, 
systematic studies assessing patient feedback and satisfaction as a quality measure are scarce. 
According to a British report titled "High-Quality Care for All,7 patient safety, patient 
experience and effectiveness of care should represent the three main dimensions of quality in 
healthcare. Thus, the mandatory use of patient-related outcome measures (PROMs)8 has been 
suggested for quality improvement programs.2, 9  
As part of a national quality improvement program for endoscopic procedures,10 this 
study was conducted to evaluate the patient pain experience and satisfaction related to ERCP 
procedures. The main objective involved evaluating self-reported patient pain and 
satisfaction; additionally, this study sought to identify possible predictors for these measures.  
 



The national quality assurance program for endoscopic activity in Norway was organized by 
Gastronet.10 The voluntary reporting of consecutive ERCP procedures from several hospitals 
and their collection into a clinical database is part of the official QA platform for the 
Norwegian Gastroenterological Association (NGA).11  
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All consecutive patients aged 18 years or older who were scheduled for planned or 
emergency ERCP were included in this study. Information regarding the total number of 
ERCPs performed at each hospital in the country during the study period was available.12 
Updated activity figures were supplemented and confirmed by each participating endoscopy 
unit. During the 36-month study period, the hospitals began their prospective reporting at 
different times. Consequently, several hospitals reported their ERCP activity for a shorter 
time period. With respect to the completeness of the data, 11 hospitals fulfilled the inclusion 
criteria for this study, and they reported prospectively on 2808 consecutive ERCP 
procedures.13 
 


				 
Data regarding patient demographics, clinical characteristics, sedation regimes and 
complications were recorded prospectively. Information concerning undesirable events that 
occurred during a 30-day follow-up period was obtained by examining hospital records or 
outpatient clinic notes or by contacting patients as necessary. All information was reported 
consecutively to the registry from each hospital by a responsible endoscopist, as was 
described previously in greater detail.11,13 On the first day after the procedure, all patients 
were asked to complete a short questionnaire.14 The form, which included a four-point verbal 
rating scale for pain (4-VRS), was previously validated15 and has been used for patient 
assessment following colonoscopy.14 An English translation of the form is provided as an 
appendix (see Appendix 1).   
The patients were categorized according to the hospital type, annual hospital ERCP 
volume and the ASA (American Society of Anesthesiologists) physical status classification 
system.16 In addition, the type and severity of the complications17 encountered during and 
136 4 

 
after the ERCP and during the 30-day follow-up period were recorded by the responsible 
endoscopist. No particular instructions were given regarding the ERCP procedure, including 
the sedation procedures, at the participating hospitals.  
 

The PROMs used for this study included patient-reported pain (as experienced during and 
after the procedure but reported on the first day after the ERCP) and general patient-reported 
satisfaction regarding the information provided about the examination and the overall 
management of the procedure (please see 
	at an appendix at the end of the 
manuscript).


	
This study was approved by the Norwegian Social Science Data service and the National 
Data Inspectorate. This study is also part of the Gastronet QA program. Thus, further 
evaluation and approval by the Regional Ethics Committee for Medical and Health Research 
was not required.   
 

PASW Statistics 18.0 for Mac (SPSS Inc., Chicago, IL, USA) was used for the statistical 
analysis. Descriptive statistics, with numbers, percentages, medians and interquartile ranges 
(IQRs), were used to characterize the study population and demographic data. For 
comparisons of categorical variables, the chi-square or Fisher's exact tests were applied as 
appropriate. To identify significant independent variables for patient satisfaction, pertinent 
clinical risk factors were analyzed by univariate logistic regression analysis. Variables with 
a  < 0.25 in the univariate analyses were included in the multivariate logistic regression 
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model. Stepwise forward and backward selection procedures were used to identify the 
variables for inclusion in the final model. In the final multivariable models, adjusted odds 
ratios (ORs) with 95% confidence intervals (CIs) were calculated, and the relevant 
interactions were tested. Case-wise deletion of cases with missing values was used, and 
goodness of fit was verified using the Hosmer-Lemeshow test. All test were two-tailed, and 
statistical significance was defined as  < 0.05. 
 

	

Fourteen hospitals reported their ERCP procedures to the registry between January 2007 and 
December 2009. However, only 11 hospitals, including two university hospitals, five central 
hospitals, and four general district hospitals, met the inclusion criteria. High quality data 
recorded from 2808 procedures were available for further evaluation, which comprised 
94.6% of the performed procedures at the hospitals during the time of registration.11,13 
Patients’ self-reported questionnaires were received for 1477 procedures (52.6%) (
	), 
and the age and sex distributions were similar for responders and non-responders (). 
However, a significantly lower response rate ( < 0.001) was observed for patients with 
higher ASA scores (). 
The main indication for ERCP was biliary therapy (91.6% of the procedures) (
) and bile duct obstructions, with common bile duct stones (CBDSs) (1359, 48.5%) and bile 
duct strictures (892, 31.8%) being the most common findings. Successful CBD cannulation 
was achieved in 91.1% of the procedures. These procedures were performed by 48 
endoscopists, and the majority (i.e., >80%) of the ERCPs were performed as in-patient 
procedures. Conscious sedation using midazolam, diazepam, or these drugs in combination 
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“No pain” or “slight pain” after the procedure was reported in 724 (49.8%) and 462 (31.8%) 
procedures, respectively, which comprised the majority (81.6%) of the procedures. 
Nevertheless, “moderate pain” or “severe pain” was experienced after 157 (10.8%) and 112 
(7.7%) ERCP procedures, respectively. The pain lasted less than 1 h in 123 patients (17.9%), 
between 1 and 3 h in 157 patients (22.9%), between 3 and 6 h in 115 patients (16.8%), and at 
least 6 h in 291 patients (29.6%). The univariate regression analysis revealed that female 
gender, younger age, university hospital, pre-cut sphincterotomy (EST), use of a guide-wire, 
biliary self-expanding metal stent (SEMS) placement, biliary leakage, post-ERCP pancreatitis 
(PEP), post-procedure cholangitis, longer procedure time, and pain during the procedure 
served as predictive factors for moderate to severe pain after the ERCP. Patients who suffered 
from moderate or severe pain after the ERCP were significantly less satisfied with the patient 
information and the ERCP treatment in general compared to those who did not report pain.  
In the multivariate regression analysis ), female gender, younger age, pre-cut 
EST, use of a guide-wire, insertion of a SEMS, and the occurrence of PEP or a post-
procedure cholangitis predicted moderate to severe pain after the ERCP. Undergoing the 
procedure at a university hospital was an independent predictor of increased pain experienced 
after the procedure. 
  
					
A univariate regression analysis showed significant (< 0.001) differences between sedation 
regimens and pain experienced during ERCP procedures. Differences regarding routine 
sedation procedures and analgesia between the participating hospitals were also observed.  
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Intravenous administration of midazolam ( 5 mg) and pethidine ( 50 mg) was employed in 
904 ERCP procedures (32.4%), and this combination was most commonly used. In the 
multivariate regression analysis, this combination was associated with significantly (= 
0.015) less patient-reported pain, compared with other options and combinations.  
Moreover, pain after the ERCP procedure was experienced to significantly different 
degrees (= 0.002 among sedation regimes, but it was impossible to identify a specific 
pattern.  
 

	
A total of 1301 patients (90.9%) reported a high level of satisfaction with the information 
received from their health professionals related to the ERCP procedure. Sixty-seven patients 
(4.7%) rated that they were “not quite satisfied” with the information received, and 64 
patients (4.5%) reported that they were “dissatisfied” with the information received. 
Significant independent factors for dissatisfaction with received information, as reported by 
131 patients (4.6%), included the administration of a pre-cut EST ( = 0.001, OR 3.13 [95% 
CI: 1.61-6.09]) and either moderate to severe pain during ( < 0.001, OR 2.40 [95% CI: 1.55-
3.72]) or after the ERCP procedure ( = 0.006, OR 1.90 [95% CI: 1.21-3.00]). Moreover, 
significant differences with respect to the experience of pain between the participating 
hospitals ( = 0.008) were observed.
 
	
The level of overall satisfaction with the ERCP treatment was reported by 1416 responders 
(98.3%). While no significant differences among hospitals were identified in the univariate 
regression analysis, several factors predicted a decreased overall satisfaction.   
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In the multivariate regression analysis, the occurrence of perforation ( = 0.043, OR 
13.4 [95% CI: 1.08-166.14]), cardio-respiratory complications after ERCP ( = 0.010, OR 
21.2 [95% CI: 2.06-217.52]), and moderate to severe pain during ( = 0.003, OR 4.1 [95% 
CI: 1.65-10.43]) or after ( < 0.001, OR 6.1 [95% CI: 2.54-14.60]) the procedure were 
independent predictive factors for a decreased patient-reported satisfaction with the treatment 
received.  


 
To the best of our knowledge, this report is currently the largest study on the patient-reported 
pain experience and satisfaction related to an ERCP procedure in a general unselected 
multicenter practice reported. Pain and discomfort during and after this procedure is 
common, and many different measures to prevent or ease these undesired side-effects are 
being utilized among institutions and countries.  
While reports on ERCP outcomes regarding PROMs have not been published to date, 
the aspect of patient satisfaction in relation to the ERCP procedure has been addressed in 
three previous multicenter studies.1,5,6 However, neither the study by Colton et al.6 nor that by 
Williams et al.5 included pain evaluation as a part of the assessment. Moreover, the Italian 
study1 was restricted to patients with gallstone disease only. All reports were biased by low 
response rates or selection bias.  
Most clinicians would agree that patient satisfaction is of great importance.2,4,18 
However, the availability of reliable high-quality measurements and instruments for the 
appropriate recording of information remains a major challenge. Moreover, high-quality 
assessment techniques are difficult to implement for many reasons. First, the timing of the 
assessment and the patient reporting may be of importance; second, methods for such 
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evaluation vary across studies. Furthermore, sedation may impact both the patient’s 
experience and how he or she recalls and describes the experience.   
The study by Cohen et al.19 addressed problems related to the reliability of patient 
satisfaction measurements and showed that the answers collected from patient surveys 
depended on how the questions were presented. To address the challenges associated with 
patient self-reporting, a questionnaire originally consisting of nine items was designed by the 
Group Health Association of America (GHAA-9).2 This instrument was designed to fit the 
US health care system,2 but other versions were subsequently introduced,20 including a 
modified European version with amended pain-related questions.1 
According to patient assessments that have measured patient satisfaction following GI 
endoscopy procedures, pain and discomfort are regarded as highly important.20 Using a 
validated version of the GHAA-9 for use in ERCP patients, Yacavone et al.20 concluded that 
the GHAA-9 had inadequate content validity for measuring patient satisfaction with 
endoscopy because pain control was not assessed. Furthermore, Masci et al.1 claimed in their 
recent study that no validated patient evaluation questionnaire for ERCP procedures currently 
exists. 
We chose a very simple form comprising five questions (Appendix 1) related to pain 
experience and a validated 4-VRS.15 This form has previously been validated for 
colonoscopy examinations in more than 10,000 colonoscopy procedures.14,15,21 ERCP is 
regarded as the endoscopic gastrointestinal procedure that is associated with the highest risk 
of complications,22,23 and this procedure is performed on patients with a wide range of 
symptoms and conditions.11,24,25 Our study population consisted of two major groups of 
patients, those patients with CBDS disease and those patients with a malignant disease 
related to or affecting the biliary tract. The CBDS group was largely targeted for curative 
treatment, whereas most patients with malignancy were targeted for palliative intention. The 
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heterogeneity of the patient population made it difficult to survey or to procure appropriate 
information for all patients. Additionally, the patients’ clinical conditions on the day 
following the procedure, including their mental states and cognitive capacities, may have 
affected their self-assessed reports. We observed that patients treated with biliary stent 
procedures (i.e., the majority had a stent for palliation for malignant disease) or with severe 
comorbidity were less likely to respond to the questionnaire.  
Rather than restricting the criteria for successful ERCP treatments to factors such as 
cannulation rates, stent patency, or specific complications, additional information should be 
obtained to evaluate outcomes from the patient’s perspective.26Female patients demonstrated 
an increased risk for reporting pain both during and after the ERCP procedure; this finding is 
in agreement with previous observations related to colonoscopy.27 Moreover, longer 
procedure times also served as a risk factor for increased pain. Whereas younger age was not 
an independent risk factor for pain during the procedure, younger age was an independent 
significant risk factor for pain after the ERCP procedure. In addition, EPT was an 
independent risk factor for pain during the ERCP procedure, which indicates that patients 
with CBDSs, many of whom receive an EPT, are at increased risk for pain compared with 
patients with a malignant stricture. 
 This multi-center study mirrors routine clinical ERCP practices in Norway, which 
include university, central and general district hospitals. High endoscopist compliance for 
reporting consecutive data added to the reliability, validity, and significance of this study.  
One limitation of this study was that only 52.6% of the patients provided feedback by 
returning their questionnaires; however, this response rate is not very different from the 66% 
response rate achieved in a study from the USA6 and the 45% response rate achieved in a 
previous British study.5 In contrast, a higher response rate of 81.6% was reported for the 
study by Masci et al.,1 although this study examined 700 procedures with gallstones that were 
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performed at 15 different hospitals with generous exclusion criteria. Nonetheless, selection 
bias may to some extent have influenced the reliability and validity of this study. However, 
the study population comprised all patients over 18 years of age in unselected multicenter 
general practice. In addition, 851 of the included patients were at least 80 years of age, and 
408 (47.8%) of these patients responded by forms. Some patients had several ERCP 
procedures at different times, which may also explain why some patients did not respond 
after every procedure. While a higher response rate would have been an advantage, we are 
unaware of any comparable study with a higher response rate. The challenges and difficulties 
encountered when these questions are addressed in a clinical research setting, as in this study, 
should not be underestimated.   
To elucidate potential hidden biases, we analyzed the patterns of missing data and the 
proportions of missing patient form data according to the included variables (). The 
missing data were relatively similar for all patient groups, and unsurprisingly, we observed 
lower response rates for elderly patients and for those patients with significant co-morbidities 
(i.e., higher ASA grades), which has previously been emphasized as a general challenge with 
these types of studies.5,6  
Our questionnaire included only five questions. To more accurately identify the grade 
of satisfaction, additional questions related to the specific ERCP procedure are likely 
warranted. Moreover, grading related to the difficulty of the procedure22,28 would have been 
of interest, but this aspect was not included in the registration form. Finally, the logistics 
related to the collection of patient feedback should also be reconsidered in future studies. 
Nevertheless, as emphasized by Naylor at al.,29 only factors of particular importance should 
be included in the evaluation to achieve simple and complete reporting. Furthermore, limiting 
the number of variables is also important for analysis and statistical calculations and for the 
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prevention of challenges regarding confounders and over-fitting. Accordingly, due to these 
methodological concerns, any conclusions from this study should be interpreted with caution. 
  Adequate sedation is of particular importance for technically demanding endoscopic 
procedures.30 Moreover, appropriate attention to proper pain relief would likely improve 
patient satisfaction. Additionally, regarding the association between complications and 
postoperative pain, a reduced complication rate would likely translate into an increased 
proportion of satisfied patients. Depending on the difficulty and complexity of the 
procedure,28 along with the desires, co-morbidities and disease patterns of the patients, the 
sedation technique should be tailored and individualized. Moreover, ERCP should be 
regarded as a true surgical procedure, and more attention should be paid to procedure-related 
aspects, as suggested by the World Health Organization in the surgical checklist of safe 
surgery.31  
 A paradox exists in that most patients generally report that they are satisfied despite a 
painful procedure. However, our study shows that patient satisfaction related to the ERCP 
procedure was related to the patients’ experiences of pain during and after the procedure. 
Some caution should be taken in this interpretation because only small numbers of patients 
were dissatisfied with the treatment. Improved instruments for the appropriate reporting of 
patient-reported outcomes after ERCP should be developed and assessed by including study 
populations from various institutions and in different countries. In addition, increased 
compliance in patient reporting, as difficult it may be to achieve in routine practice, will 
contribute to the available knowledge on this important aspect of treatment.  
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